Sai Life Sciences informs about reappointment of MD & CEO

08 Aug 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III to the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 (‘Listing Regulations’), Sai Life Sciences has informed that the Board of Directors at its meeting held on Thursday, 07 August 2025, considered and approved the reappointment of Krishnamraju Kanumuri, (DIN: 00064614) Managing Director & CEO, as Managing Director & CEO of the Company for a term of five years effective from 01 September 2025, subject to approval of the members of the Company at the ensuing Annual General Meeting. The required disclosures to be made pursuant to the Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/0155 dated 11 November 2024 are enclosed.

The above information is a part of company’s filings submitted to BSE.

Sai Life Sciences Share Price

900.15 -6.95 (-0.77%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×